Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 07-2023 | 04-2023 | 01-2023 | 12-2022 | 10-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,847 | 5,246 | 3,340 | N/A | 129 |
| Marketable Securities | 123 | 135 | 134 | N/A | 194 |
| Receivables | 235 | 198 | 274 | 274 | 98 |
| Other current assets | 0 | 0 | 0 | 15 | 0 |
| TOTAL | $4,356 | $5,842 | $4,442 | $289 | $435 |
| Non-Current Assets | |||||
| PPE Net | 7 | 10 | 11 | 14 | 13 |
| Intangibles | 118 | 125 | 129 | 0 | 130 |
| Other Non-Current Assets | 8 | 19 | 33 | 348 | 249 |
| TOTAL | $133 | $154 | $173 | $362 | $392 |
| Total Assets | $4,488 | $5,996 | $4,615 | $651 | $826 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 348 | 854 | 776 | 0 | 1,604 |
| Other current liabilities | 1,313 | 1,796 | N/A | 527 | 291 |
| TOTAL | $1,661 | $2,654 | $796 | $527 | $1,932 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,661 | $2,654 | $796 | $527 | $1,932 |
| Shareholders' Equity | |||||
| Common Shares | 14,933 | 14,758 | 13,137 | N/A | 6,707 |
| Retained earnings | -14,698 | -14,123 | -12,111 | N/A | -10,147 |
| Other shareholders' equity | 2,594 | 2,707 | 2,793 | 0 | 2,335 |
| TOTAL | $2,828 | $3,342 | $3,819 | $N/A | $-1,106 |
| Total Liabilities And Equity | $4,489 | $5,996 | $4,615 | $527 | $826 |